186 related articles for article (PubMed ID: 9846957)
1. Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis.
Jin LW; Hearn MG; Ogburn CE; Dang N; Nochlin D; Ladiges WC; Martin GM
Am J Pathol; 1998 Dec; 153(6):1679-86. PubMed ID: 9846957
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis.
Vattemi G; Nogalska A; King Engel W; D'Agostino C; Checler F; Askanas V
Acta Neuropathol; 2009 May; 117(5):569-74. PubMed ID: 19280202
[TBL] [Abstract][Full Text] [Related]
3. Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles.
Vattemi G; Engel WK; McFerrin J; Askanas V
J Neurochem; 2003 Jun; 85(6):1539-46. PubMed ID: 12787072
[TBL] [Abstract][Full Text] [Related]
4. Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse.
Luo YB; Johnsen RD; Griffiths L; Needham M; Fabian VA; Fletcher S; Wilton SD; Mastaglia FL
Int J Exp Pathol; 2013 Dec; 94(6):418-25. PubMed ID: 24205796
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.
Fukuchi K; Pham D; Hart M; Li L; Lindsey JR
Am J Pathol; 1998 Dec; 153(6):1687-93. PubMed ID: 9846958
[TBL] [Abstract][Full Text] [Related]
6. BACE1 and BACE2 in pathologic and normal human muscle.
Vattemi G; Engel WK; McFerrin J; Pastorino L; Buxbaum JD; Askanas V
Exp Neurol; 2003 Feb; 179(2):150-8. PubMed ID: 12618121
[TBL] [Abstract][Full Text] [Related]
7. Rimmed vacuoles with beta-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis.
Semino-Mora C; Dalakas MC
Hum Pathol; 1998 Oct; 29(10):1128-33. PubMed ID: 9781653
[TBL] [Abstract][Full Text] [Related]
8. NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in A beta PP-overexpressing cultured human muscle fibers.
Wojcik S; Engel WK; Yan R; McFerrin J; Askanas V
Acta Neuropathol; 2007 Nov; 114(5):517-26. PubMed ID: 17764014
[TBL] [Abstract][Full Text] [Related]
9. Activation of the γ-secretase complex and presence of γ-secretase-activating protein may contribute to Aβ42 production in sporadic inclusion-body myositis muscle fibers.
Nogalska A; D'Agostino C; Engel WK; Askanas V
Neurobiol Dis; 2012 Oct; 48(1):141-9. PubMed ID: 22750528
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
11. Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis.
Vattemi G; Engel WK; McFerrin J; Buxbaum JD; Pastorino L; Askanas V
Lancet; 2001 Dec; 358(9297):1962-4. PubMed ID: 11747923
[TBL] [Abstract][Full Text] [Related]
12. Transgenic expression of beta-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology.
Moussa CE; Fu Q; Kumar P; Shtifman A; Lopez JR; Allen PD; LaFerla F; Weinberg D; Magrane J; Aprahamian T; Walsh K; Rosen KM; Querfurth HW
FASEB J; 2006 Oct; 20(12):2165-7. PubMed ID: 16940437
[TBL] [Abstract][Full Text] [Related]
13. Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis.
Chen X; Ghribi O; Geiger JD
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R829-35. PubMed ID: 18216139
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model.
Sugarman MC; Kitazawa M; Baker M; Caiozzo VJ; Querfurth HW; LaFerla FM
Neurobiol Aging; 2006 Mar; 27(3):423-32. PubMed ID: 15950323
[TBL] [Abstract][Full Text] [Related]
15. Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers.
Nogalska A; D'Agostino C; Engel WK; Klein WL; Askanas V
Acta Neuropathol; 2010 Nov; 120(5):661-6. PubMed ID: 20711838
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer-like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein.
Liskowsky W; Schliebs R
Int J Dev Neurosci; 2006; 24(2-3):149-56. PubMed ID: 16423497
[TBL] [Abstract][Full Text] [Related]
17. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
19. Enhanced release of amyloid beta-protein from codon 670/671 "Swedish" mutant beta-amyloid precursor protein occurs in both secretory and endocytic pathways.
Perez RG; Squazzo SL; Koo EH
J Biol Chem; 1996 Apr; 271(15):9100-7. PubMed ID: 8621560
[TBL] [Abstract][Full Text] [Related]
20. Immunization with amyloid-beta attenuates inclusion body myositis-like myopathology and motor impairment in a transgenic mouse model.
Kitazawa M; Vasilevko V; Cribbs DH; LaFerla FM
J Neurosci; 2009 May; 29(19):6132-41. PubMed ID: 19439591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
